DocuSign (NASDAQ:DOCU – Get Rating) had its price target dropped by research analysts at UBS Group from $170.00 to $110.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s target price points to a potential upside of 8.50% from the company’s current price.
DOCU has been the subject of several other reports. Zacks Investment Research lowered shares of DocuSign from a “buy” rating to a “hold” rating and set a $128.00 target price for the company. in a report on Tuesday, February 15th. JPMorgan Chase & Co. cut shares of DocuSign from a “neutral” rating to an “underweight” rating and set a $175.00 price objective for the company. in a report on Friday, December 3rd. Wolfe Research cut DocuSign from an “outperform” rating to a “market perform” rating in a report on Monday, December 6th. Robert W. Baird lowered their price target on DocuSign from $330.00 to $220.00 and set an “outperform” rating on the stock in a research report on Friday, December 3rd. They noted that the move was a valuation call. Finally, Citigroup cut their price objective on DocuSign from $389.00 to $231.00 and set a “buy” rating for the company in a research report on Friday, December 3rd. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $238.28.
Shares of DocuSign stock opened at $101.38 on Monday. The stock has a market cap of $20.06 billion, a PE ratio of -174.79, a price-to-earnings-growth ratio of 10.91 and a beta of 0.93. The firm has a fifty day moving average price of $126.48 and a 200 day moving average price of $206.41. DocuSign has a 1 year low of $100.00 and a 1 year high of $314.76. The company has a debt-to-equity ratio of 3.00, a current ratio of 0.96 and a quick ratio of 0.96.
DocuSign (NASDAQ:DOCU – Get Rating) last posted its earnings results on Thursday, December 2nd. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.46 by $0.12. DocuSign had a negative return on equity of 9.12% and a negative net margin of 5.72%. The firm had revenue of $545.46 million for the quarter, compared to analyst estimates of $531.25 million. During the same period last year, the company earned ($0.21) earnings per share. DocuSign’s revenue for the quarter was up 42.4% compared to the same quarter last year. As a group, equities analysts expect that DocuSign will post 0.07 EPS for the current year.
In other news, Director Enrique T. Salem sold 37,764 shares of the stock in a transaction on Tuesday, December 21st. The stock was sold at an average price of $148.48, for a total transaction of $5,607,198.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Daniel D. Springer acquired 33,675 shares of DocuSign stock in a transaction that occurred on Tuesday, December 7th. The stock was bought at an average price of $143.95 per share, for a total transaction of $4,847,516.25. The disclosure for this purchase can be found here. Insiders sold a total of 75,264 shares of company stock worth $10,680,574 over the last quarter. 3.87% of the stock is currently owned by company insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Souders Financial Advisors boosted its holdings in DocuSign by 1.1% during the 3rd quarter. Souders Financial Advisors now owns 3,659 shares of the company’s stock valued at $942,000 after acquiring an additional 39 shares during the period. Global Retirement Partners LLC boosted its stake in shares of DocuSign by 15.2% in the third quarter. Global Retirement Partners LLC now owns 303 shares of the company’s stock valued at $78,000 after purchasing an additional 40 shares during the period. Berman Capital Advisors LLC grew its holdings in shares of DocuSign by 1.2% in the third quarter. Berman Capital Advisors LLC now owns 3,523 shares of the company’s stock valued at $906,000 after purchasing an additional 42 shares in the last quarter. Berkeley Capital Partners LLC increased its stake in DocuSign by 4.2% during the 3rd quarter. Berkeley Capital Partners LLC now owns 1,036 shares of the company’s stock worth $267,000 after buying an additional 42 shares during the period. Finally, Continuum Advisory LLC lifted its holdings in DocuSign by 5.1% during the 3rd quarter. Continuum Advisory LLC now owns 891 shares of the company’s stock worth $229,000 after buying an additional 43 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.
DocuSign Company Profile
DocuSign, Inc provides cloud-based electronic signature solutions. Its cloud based electronic signature platform helps companies and individuals securely collect information, automate data workflows and sign anything. The firm automates manual, paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation and storage.